Related Experiment Video

Updated: Nov 20, 2025

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

603

Targeting WASF3 Signaling in Metastatic Cancer

Reid Loveless1, Yong Teng1,2,3

  • 1Department of Oral Biology and Diagnostic Sciences, Dental College of Georgia, Augusta University, Augusta, GA 30912, USA.

International Journal of Molecular Sciences
|January 20, 2021
PubMed

Insights

Targeting WASF3, a key protein in cancer cell invasion, offers a promising strategy for suppressing metastasis. This approach is effective across various tumor types, independent of their genetic makeup.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Cancer metastasis involves distinct genetic pathways separate from tumor growth.
  • Wiskott-Aldrich syndrome protein family member 3 (WASF3) regulates actin dynamics and cancer cell invasion.
  • WASF3 acts as a crucial scaffolding protein in metastatic signaling complexes.

Purpose of the Study:

  • To review the critical role of WASF3 in regulating signaling pathways that promote cancer cell invasion and metastasis.
  • To highlight WASF3 as a potential therapeutic target for metastasis suppression.

Main Methods:

  • Literature review focusing on WASF3's function in cancer metastasis.
  • Analysis of WASF3's role in actin cytoskeleton dynamics and signaling complex assembly.
  • Examination of targeting WASF3 at transcriptional, protein stability, and phosphorylation levels.

Main Results:

  • WASF3 is a master regulator of cancer cell invasion and metastasis.
  • WASF3 orchestrates metastatic signaling by assembling protein complexes.
  • Targeting WASF3 demonstrates significant promise for inhibiting metastasis.

Conclusions:

  • WASF3 plays a pivotal and distinct role in promoting cancer cell invasion and metastasis.
  • Interventions targeting WASF3 offer a potential strategy for broad-spectrum metastasis suppression.
  • Understanding WASF3's regulatory mechanisms is key to developing novel anti-metastasis therapies.
Keywords:
WASF3cancerdrug targetmetastasissignaling network

More Related Videos

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

1.9K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.7K

Related Concept Videos

Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.0K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
9.7K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.4K